Influenza virus antigens — Drug Target

All drugs that target Influenza virus antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Influenza vaccine

Phase 2 pipeline (1)

• GlaxoSmithKline Biologicals' influenza vaccine GSK576389A · GlaxoSmithKline · Influenza vaccine · Vaccines
  Induces an immune response against influenza viruses through the presentation of viral antigens to the immune system.